OPTH

distress 6/10 · elevated risk

$4.530%today-26% from 52w high

optimihealth.caFounded 2020Princeton, BCDrug Manufacturers - Specialty & Generic

Revenue

pre-revenue

Liquidity

$0M

Runway

0.0 yrs

Shares 1y

—

Price & events

-25.6% over 6M

CatalystRating changeDilutionFinancingdashed = today

-0.3%

-8.8%

+8.5%

—

-25.6%

All

Overview

Volume: 1.14K
52 Week Range: $4.01 – $6.08
Float Shares: 4.16M
% Held by Insiders: 0.60%
% Held by Institutions: 8.78%
RVOL: 0.01x
Beta: 1.59

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: — · 1 offerings/1y · 0 PIPEs

2026-05-20424B4offering
2026-05-19F-1/Ashelf_registration
2026-05-19EFFECTshelf_effective
2026-04-23F-1/Ashelf_registration
2026-04-21F-1/Ashelf_registration
2026-04-21F-1/Ashelf_registration
2026-04-16F-1/Ashelf_registration

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified